glp 1 agonist trials Lilly orforglipron oral GLP-1 phase 3 weight loss trial Timeline of GLP-1 discovery and

Conversely, we found little evidence that GLP-1RAs may cause or exacerbate cognitive impairment, which is of importance to patients who may need to take these medications for their currently licensed (and expanding) indications

They are also administered at different doses and last for different durations

Abstract Type 2 diabetes mellitus (T2DM) and obesity are metabolic disorders characterized by excess cardiovascular risk

G-Protein Coupled Receptors (GPCRs): Signaling Pathways, Characterization, and Functions in Insect Physiology and Toxicology

Akanksha has contributed to 250+ research reports, helping manufacturers, suppliers, and investors make informed decisions in markets shaped by regulation, innovation, and global demand shifts

Klein, D